Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 13/20 | 0.94 |
| ▸ | CA1 | P00915 | 13/20 | 0.94 |
| ▸ | CA9 | Q16790 | 13/20 | 0.94 |
| ▸ | CA2 | P00918 | 12/20 | 0.94 |
| ▸ | EHMT2 | Q96KQ7 | 3/20 | 0.94 |
| ▸ | EHMT1 | Q9H9B1 | 3/20 | 0.94 |
| ▸ | CA4 | P22748 | 2/20 | 0.94 |
| ▸ | ABCB11 | O95342 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | GSDMD | P57764 | 2/20 | 0.48 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.48 |
| ▸ | MGLL | Q99685 | 4/20 | 0.46 |
| ▸ | PHGDH | O43175 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | TP53 | P04637 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | ALOX12 | P18054 | 2/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ditiocarb SCHEMBL21990205 | 0.97 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL43743 | 0.94 | — | — | |
| Ditiocarb SCHEMBL48605 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL10539605 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL3685439 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL25284942 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL11436990 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL22372292 | 0.94 | — | — | |
| Ditiocarb SCHEMBL672398 | 0.94 | CA12 (0.94) | CA12CA1CA9CA2EHMT2 | |
| Ditiocarb SCHEMBL168133 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260048028-A1 | Methods of Use for Disulfiram and Metabolites Thereof | PS THERAPY INC (US) | 2026-02-19 | — | — | US | claimed |
| CN-114411476-B | Regenerated essence fixing wearing layer and construction method thereof | 杭州天禧公路养护科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| WO-2024039636-A1 | METHODS OF USE FOR DISULFIRAM AND METABOLITES THEREOF | PS THERAPY, INC. (US) | 2024-02-22 | — | — | WO | claimed |
| CN-115429780-A | Use of disulfiram for protecting gastrointestinal tissue against damage caused by ionizing radiation | 中国人民解放军军事科学院军事医学研究院 | 2022-12-06 | — | — | CN | claimed |
| CN-112592594-B | Emulsified modified asphalt for micro surfacing and preparation thereof | 杭州天禧公路养护科技有限公司 | 2022-10-21 | — | — | CN | claimed |
| CN-114411476-A | Regenerated fine-solidified wearing layer and construction method thereof | 杭州天禧公路养护科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-114292524-A | Super micro-surfacing emulsified asphalt | 贵州黔和物流有限公司 | 2022-04-08 | — | — | CN | claimed |
| CN-112592594-A | Emulsified modified asphalt for micro surfacing and preparation thereof | 杭州天禧公路养护科技有限公司 | 2021-04-02 | — | — | CN | claimed |
| CN-110697766-A | Preparation method of zinc-doped lead sulfide quantum dots | 武汉理工大学 | 2020-01-17 | — | — | CN | claimed |
| US-20170207362-A1 | METHOD FOR FORMING THIN FILM HAVING SULFIDE SINGLE-CRYSTAL NANOPARTICLES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2017-07-20 | — | — | US | claimed |
| US-20160181452-A1 | COMPOUND SOLAR CELL AND METHOD FOR FORMING THIN FILM HAVING SULFIDE SINGLE-CRYSTAL NANOPARTICLES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2016-06-23 | — | — | US | claimed |
| US-8273810-B2 | Polyisoprene articles and process for making the same | ALLEGIANCE CORPORATION (US) | 2012-09-25 | — | — | US | claimed |
| US-20110203596-A1 | POLYISOPRENE ARTICLES AND PROCESS FOR MAKING THE SAME | ALLEGIANCE CORPORATION (US) | 2011-08-25 | — | — | US | claimed |
| JP-2010536987-A | — | — | 2010-12-02 | — | — | JP | claimed |
| EP-2183303-A1 | COMPOUNDING FORMULATIONS FOR PRODUCING ARTICLES FROM GUAYULE NATURAL RUBBER | Yulex Corporation (US) | 2010-05-12 | — | — | EP | claimed |
| WO-2009025675-A1 | COMPOUNDING FORMULATIONS FOR PRODUCING ARTICLES FROM GUAYULE NATURAL RUBBER | YULEX CORPORATION (US) | 2009-02-26 | — | — | WO | claimed |
| US-20090054595-A1 | Compounding Formulations for Producing Articles from Guayule Natural Rubber | YULEX CORPORATION | 2009-02-26 | — | — | US | claimed |
| US-4098858-A | DUSTLESS FREE FLOWING RUBBER ADDITIVES | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1978-07-04 | — | — | US | claimed |
| US-12622232-B2 | Advanced self aligned multiple patterning using tin oxide | LAM RESEARCH CORPORATION (US) | 2026-05-05 | — | — | US | disclosed |
| US-3985707-A | HEAT AGING RESISTANCE | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1976-10-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622232-B2 | Advanced self aligned multiple patterning using tin oxide | SMCHD1, NOTCH3, NOTCH2 | CA12 360/4885CA1 735/4885CA9 2208/4885 |
| US-20260048028-A1 | Methods of Use for Disulfiram and Metabolites Thereof | ALDH1A2, MGMT, TST | CA12 122/4885CA1 208/4885CA9 389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.